Standout Papers

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukem... 2016 2026 2019 2022 300
  1. Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia (2016)
    Gabriel Étienne, Joëlle Guilhot et al. Journal of Clinical Oncology

Immediate Impact

36 from Science/Nature 62 standout
Sub-graph 1 of 18

Citing Papers

Mitochondrial transfer mediates endothelial cell engraftment through mitophagy
2024 StandoutNature
Mitochondrial RNA modifications shape metabolic plasticity in metastasis
2022 StandoutNature
9 intermediate papers

Works of Martine Gardembas being referenced

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
2006
Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta
2002

Author Peers

Author Last Decade Papers Cites
Martine Gardembas 1820 1615 1062 63 2.6k
Michel Tulliez 1535 1210 778 74 2.3k
Hugues de Lavallade 2520 1762 1021 80 3.2k
John Nicoll 1823 1376 906 29 3.2k
Stuart L. Goldberg 1758 1355 872 100 2.8k
Aude Charbonnier 2672 1917 1147 68 3.6k
A. Georgii 1291 1302 511 114 2.8k
Markus Pfirrmann 1873 1672 948 68 2.4k
Zbigniew Rudzki 2650 2185 1523 101 3.7k
Marilina Amabile 2413 1584 1049 78 2.9k
Christoph Walz 778 666 682 69 2.0k

All Works

Loading papers...

Rankless by CCL
2026